Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mangoceuticals Inc.

    NASDAQ: MGRX · Real-Time Price · USD
    2.05
    0.04 (1.99%)
    At close: Jun 13, 2025, 3:59 PM
    2.01
    -1.95%
    Pre-market: Jun 16, 2025, 05:05 AM EDT

    Mangoceuticals Statistics

    Share Statistics

    Mangoceuticals has 9.88M shares outstanding. The number of shares has increased by -79.17% in one year.

    Shares Outstanding

    n/a
    		 9.88M

    Shares Change (YoY)

    n/a
    		 -79.17%

    Shares Change (QoQ)

    n/a
    		 107.87%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 4.8M

    Failed to Deliver (FTD) Shares

    n/a
    		 212

    FTD / Avg. Volume

    n/a
    		 0.07%

    Short Selling Information

    The latest short interest is 249.33K, so 2.26% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 249.33K

    Short % of Shares Out

    n/a
    		 2.26%

    Short % of Float

    n/a
    		 2.71%

    Short Ratio (days to cover)

    n/a
    		 1.11

    Valuation Ratios

    The PE ratio is -0.55 and the forward PE ratio is null. Mangoceuticals's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.55

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 10.12

    Forward PS

    n/a
    		 1133.4

    PB Ratio

    n/a
    		 0.34

    P/FCF Ratio

    n/a
    		 -0.98

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Mangoceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.05, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 0.05

    Quick Ratio

    n/a
    		 0.05

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.04

    Interest Coverage

    n/a
    		 -581.9

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $205,291

    Profits Per Employee

    n/a
    		 $-2,902,000

    Employee Count

    n/a
    		 3

    Asset Turnover

    n/a
    		 0.03

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -57.29% in the last 52 weeks. The beta is 2.76, so Mangoceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.76

    52-Week Price Change

    n/a
    		 -57.29%

    50-Day Moving Average

    n/a
    		 1.87

    200-Day Moving Average

    n/a
    		 2.86

    Relative Strength Index (RSI)

    n/a
    		 52.03

    Average Volume (20 Days)

    n/a
    		 303,253

    Income Statement

    In the last 12 months, Mangoceuticals had revenue of 615.87K and earned -8.71M in profits. Earnings per share was -4.84.

    Revenue

    n/a
    		 615.87K

    Gross Profit

    n/a
    		 379.96K

    Operating Income

    n/a
    		 -7.97M

    Net Income

    n/a
    		 -8.71M

    EBITDA

    n/a
    		 -7.96M

    EBIT

    n/a
    		 -8.69M

    Earnings Per Share (EPS)

    n/a
    		 -4.84
    Full Income Statement

    Balance Sheet

    The company has 58.65K in cash and 214.96K in debt, giving a net cash position of -156.31K.

    Cash & Cash Equivalents

    n/a
    		 58.65K

    Total Debt

    n/a
    		 214.96K

    Net Cash

    n/a
    		 -156.31K

    Retained Earnings

    n/a
    		 -20.81M

    Total Assets

    n/a
    		 21.75M

    Working Capital

    n/a
    		 -1.33M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -4.86M and capital expenditures 0, giving a free cash flow of -4.86M.

    Operating Cash Flow

    n/a
    		 -4.86M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -4.86M

    FCF Per Share

    n/a
    		 -2.46
    Full Cash Flow Statement

    Margins

    Gross margin is 50.15%, with operating and profit margins of -1684.48% and -1839.61%.

    Gross Margin

    n/a
    		 50.15%

    Operating Margin

    n/a
    		 -1684.48%

    Pretax Margin

    n/a
    		 -1839.84%

    Profit Margin

    n/a
    		 -1839.61%

    EBITDA Margin

    n/a
    		 -1684.48%

    EBIT Margin

    n/a
    		 -1294.42%

    FCF Margin

    n/a
    		 -789.74%

    Dividends & Yields

    MGRX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for MGRX.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Oct 16, 2024. It was a backward split with a ratio of 1:15.

    Last Split Date

    n/a
    		 Oct 16, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:15

    Scores

    Altman Z-Score

    n/a
    		 6.54

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist